Mehran, Roxana

Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease

Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine

Acute Myeloid Leukemia ResearchAtherosclerosis and Cardiovascular Diseases

Cited by 2,683

Prevention of bleeding in patients with atrial fibrillation undergoing PCI

Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., van Eickels, M., et al. (2016) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,590

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease

Khera, A. V., Emdin, C. A., Drake, I., Natarajan, P., Bick, A. G., Cook, N. R., Chasman, D. I., Baber, U., Mehran, R., Rader, D. J., et al. (2016) · New England Journal of Medicine

Genetic Associations and EpidemiologyNutrition, Genetics, and Disease

Cited by 1,460

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery

Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Circulation

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 1,355

Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation

Lopes, R. D., Heizer, G., Aronson, R., Vora, A. N., Massaro, T., Mehran, R., Goodman, S. G., Windecker, S., Darius, H., Li, J., et al. (2019) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,228

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

Hicks, K. A., Mahaffey, K. W., Mehran, R., Nissen, S. E., Wiviott, S. D., Dunn, B., Solomon, S. D., Marler, J. R., Teerlink, J. R., Farb, A., et al. (2018) · Circulation

Statistical Methods in Clinical TrialsPharmacovigilance and Adverse Drug Reactions

Cited by 750

Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting

Natarajan, P., Young, R., Stitziel, N. O., Padmanabhan, S., Baber, U., Mehran, R., Sartori, S., Fuster, V., Reilly, D. F., Butterworth, A., et al. (2017) · Circulation

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 570

Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association

Mehta, L. S., Warnes, C. A., Bradley, E., Burton, T., Economy, K., Mehran, R., Safdar, B., Sharma, G., Wood, M., Valente, A. M., et al. (2020) · Circulation

Cardiovascular Issues in PregnancyPregnancy and preeclampsia studies

Cited by 464

Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults

Baber, U., Mehran, R., Sartori, S., Schoos, M. M., Sillesen, H., Muntendam, P., Garcia, M. J., Gregson, J., Pocock, S., Falk, E., et al. (2015) · Journal of the American College of Cardiology

Cardiac Imaging and DiagnosticsCardiovascular Health and Disease Prevention

Cited by 461

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease

Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · The Journal of Thoracic and Cardiovascular Surgery

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 304

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials

Guedeney, P., Giustino, G., Sorrentino, S., Claessen, B. E., Camaj, A., Kalkman, D. N., Vogel, B., Sartori, S., De Rosa, S., Baber, U., et al. (2022) · European Heart Journal

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 208

Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans

Sillesen, H., Sartori, S., Sandholt, B., Baber, U., Mehran, R., & Fuster, V. (2018) · European Heart Journal - Cardiovascular Imaging

Cardiovascular Health and Disease PreventionCerebrovascular and Carotid Artery Diseases

Cited by 204

Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention

Angiolillo, D. J., Baber, U., Sartori, S., Briguori, C., Dangas, G., Cohen, D. J., Mehta, S. R., Gibson, C. M., Chandiramani, R., Huber, K., et al. (2020) · Journal of the American College of Cardiology

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 87

Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis

Natarajan, P., Bis, J. C., Bielak, L. F., Cox, A. J., Dörr, M., Feitosa, M. F., Franceschini, N., Guo, X., Hwang, S.-J., Isaacs, A., et al. (2016) · Circulation: Cardiovascular Genetics

Genetic Associations and EpidemiologyAtherosclerosis and Cardiovascular Diseases

Cited by 66

SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis

Razuk, V., Chiarito, M., Cao, D., Nicolas, J., Pivato, C. A., Camaj, A., Power, D., Beerkens, F., Jones, D., Alter, A., et al. (2022) · European Heart Journal - Cardiovascular Pharmacotherapy

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 41

Diagnostic Value of Aortic Valve Calcification Levels in the Assessment of Low-Gradient Aortic Stenosis

Adrichem, R., Hokken, T. W., Bouwmeester, S., Abdelkarim, O., Vogel, B., Blusztein, D. I., Veulemans, V., Kuneman, J. H., Geleijnse, M. L., Verhemel, S., et al. (2024) · JACC: Cardiovascular Imaging

Cardiac Valve Diseases and TreatmentsCardiac Imaging and Diagnostics

Cited by 38

1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI

Kunadian, V., Gitto, M., Vogel, B., Sartori, S., Angiolillo, D. J., Bhatt, D. L., Chehab, B. M., Feng, Y., de la Torre Hernandez, J. M., Krucoff, M. W., et al. (2025) · JACC: Cardiovascular Interventions

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 7

Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries

Batchelor, W. B., Damluji, A. A., Yong, C., Fiuzat, M., Barnett, S. D., Kandzari, D. E., Sherwood, M. W., Epps, K. C., Tehrani, B. N., Allocco, D. J., et al. (2021) · American Heart Journal

Ethics in Clinical ResearchDiversity and Career in Medicine

Cited by 7

Are adverse events following an invasive strategy in patients with non‐ST‐segment elevation acute coronary syndromes more frequent at US sites versus Non‐US sites? analysis from the ACUITY trial

Tobbia, P., Brodie, B. R., Stuckey, T., McLaurin, B. T., Cox, D. A., Fahy, M., Xu, K., Mehran, R., & Stone, G. W. (2013) · Catheterization and Cardiovascular Interventions

Acute Myocardial Infarction ResearchAntiplatelet Therapy and Cardiovascular Diseases

Cited by 2

Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I

Naghavi, M., Azimi, A., Atlas, K., Reeves, A. P., Zhang, C., Mirjalili, S. R., Mozafarybazargany, M., Jolfayi, A. G., Hashemi, A., Atlas, T., et al. (2026) · American Journal of Preventive Cardiology

Cardiac Imaging and DiagnosticsArtificial Intelligence in Healthcare and Education

Cited by 2